1. Home
  2. HESM vs ALKS Comparison

HESM vs ALKS Comparison

Compare HESM & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hess Midstream LP Share

HESM

Hess Midstream LP Share

HOLD

Current Price

$39.15

Market Cap

4.9B

Sector

Energy

ML Signal

HOLD

Logo Alkermes plc

ALKS

Alkermes plc

HOLD

Current Price

$34.26

Market Cap

4.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HESM
ALKS
Founded
2014
1987
Country
United States
Ireland
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.9B
4.5B
IPO Year
2019
2012

Fundamental Metrics

Financial Performance
Metric
HESM
ALKS
Price
$39.15
$34.26
Analyst Decision
Hold
Buy
Analyst Count
8
14
Target Price
$41.57
$43.29
AVG Volume (30 Days)
1.1M
2.7M
Earning Date
05-04-2026
04-30-2026
Dividend Yield
7.77%
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.43
Revenue
$1,621,300,000.00
$1,475,899,000.00
Revenue This Year
$1.59
$24.26
Revenue Next Year
$3.10
$4.63
P/E Ratio
$13.07
$23.08
Revenue Growth
8.41
N/A
52 Week Low
$31.63
$25.17
52 Week High
$44.14
$36.48

Technical Indicators

Market Signals
Indicator
HESM
ALKS
Relative Strength Index (RSI) 53.89 63.80
Support Level $38.56 $26.80
Resistance Level $40.62 $35.21
Average True Range (ATR) 0.87 1.38
MACD -0.16 0.67
Stochastic Oscillator 58.19 76.79

Price Performance

Historical Comparison
HESM
ALKS

About HESM Hess Midstream LP Share

Hess Midstream LP owns, operates, develops, and acquires a diverse set of midstream assets and provides fee-based services to Hess and third-party customers. It conducts its business through three operating segments: gathering, processing and storage, and terminaling and exporting. The company derives the maximum revenue from the gathering segment. Its gathering segment consists of the following assets namely Natural Gas Gathering and Compression; Crude Oil Gathering and Produced Water Gathering and Disposal.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: